Cargando…
Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments
Fumaric acid esters (FAEs) are licensed for the treatment of moderate‐to‐severe psoriasis in Germany but are also used off‐label in many other countries. We conducted this systematic review to synthesize the highest‐quality evidence for the benefits and risks of FAEs for psoriasis. Our primary outco...
Autores principales: | Atwan, A., Ingram, J.R., Abbott, R., Kelson, M.J., Pickles, T., Bauer, A., Piguet, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095877/ https://www.ncbi.nlm.nih.gov/pubmed/27087044 http://dx.doi.org/10.1111/bjd.14676 |
Ejemplares similares
-
Fumaric acid esters in the management of psoriasis
por: Balak, Deepak MW
Publicado: (2015) -
ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review
por: Appleton, Katherine M, et al.
Publicado: (2016) -
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Han, Mi Ah, et al.
Publicado: (2021) -
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality
por: Ingram, J.R., et al.
Publicado: (2016) -
Home-based versus centre-based cardiac rehabilitation: abridged Cochrane systematic review and meta-analysis
por: Buckingham, S A, et al.
Publicado: (2016)